Kristian D Stensland
Assistant Professor of Urology
Assistant Professor of Learning Health Sciences, Medical School
Department of Urology
NCRC Building 16; 2800 Plymouth Road
Ann Arbor, Michigan 48109
[email protected]

Available to mentor
Kristian D Stensland
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • Manage Your Profile
    About

    Dr. Kristian Stensland is a urologic oncologist and health services researcher. His research focuses on improving the conduct, efficiency, and equity of clinical trials through informatics, infrastructure, and implementation science.

    Qualifications
    • MS
      University of Michigan, 2021
    • MPH
      Harvard TH Chan School of Public Health, 2017
    • MD
      Icahn School of Medicine at Mount Sinai, 2014
    • BA
      Vanderbilt University, 2009
    Center Memberships
    • Center Member
      Precision Health Initiative
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Rogel Cancer Center
    Research Overview

    My research focuses on improving the conduct, efficiency, and equity of clinical trials through informatics, infrastructure, and implementation science.

    Recent Publications See All Publications
    • Proceeding / Abstract / Poster
      A Quality Improvement Study on Pathology Explanation Clinics in Veterans with Prostate Cancer
      Lapedis C, bergholtz S, Belknap A, Choi E, Stensland K, Kaplan J, Hawley ST, Zikmund-Fisher B, Amjadi D. 2025 Mar 20;
    • Journal Article
      THE ASSOCIATION BETWEEN RACE/ETHNICITY AND TRUST IN SOURCES OF CANCER INFORMATION IN PATIENTS WITH UROLOGIC CANCERS
      Dhir A, Maganty A, Stensland KD, Herrel LA, Sekar RR. Urologic Oncology Seminars and Original Investigations, 2025 Mar 1; 43 (3): 10 DOI:10.1016/j.urolonc.2024.12.027
    • Journal Article
      Structural inequities in the availability of prostate cancer clinical trial opportunities.
      Sekar RR, Zebib L, Stensland KD, Herrel LA. J Natl Cancer Inst, 2025 Feb 26; DOI:10.1093/jnci/djaf047
      PMID: 40036373
    • Proceeding / Abstract / Poster
      Impact of PSMA PET staging on initial treatment in newly diagnosed prostate cancer: An emulated randomized controlled trial.
      Miller SR, Tucker Gonzalez R, Jackson WC, Caram MV, Tsao PA, Stensland K, Shah Y, Wale D, Elliott D, Wong KK, Viglianti B, Caverly TC, Hofer T, Saini SD, Green MD, Schipper MJ, Dess RT, Bryant AK. Journal of Clinical Oncology, 2025 Feb 20; 43 (5_suppl): 350 - 350. DOI:10.1200/jco.2025.43.5_suppl.350
    • Journal Article
      Prostate Cancer Mortality in Men Aged 70 Years Who Recently Underwent Prostate-Specific Antigen Screening
      Chung DH, Caverly TJ, Schipper MJ, Hofer TP, Gulati R, Rose BS, Caram MEV, Tsao PA, Stensland KD, Elliott D, Saini SD, Bryant AK. JAMA network open, 2025 Feb 3; 8 (2): e2459766 DOI:10.1001/jamanetworkopen.2024.59766
      PMID: 39951264
    • Journal Article
      Association of Community-Level Social Vulnerability with Clinical Trial Discussion and Participation among Cancer Survivors
      Sekar RR, Maganty A, Stensland KD, Herrel LA. JCO Oncology Practice, 2025 Feb 1; 21 (2): 235 - 244. DOI:10.1200/OP.24.00206
      PMID: 39208361
    • Journal Article
      Advancing trial recruitment science through enhanced study design
      Lewicki P, Stensland K. Cancer, 2025 Jan 15; 131 (2): DOI:10.1002/cncr.35703
      PMID: 39810289
    • Journal Article
      Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System
      Miller SR, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Shah Y, Wale D, Wong KK, Viglianti BL, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. Journal of Nuclear Medicine, 2025 Jan 1; 66 (1): 75 - 83. DOI:10.2967/jnumed.124.268555
      PMID: 39753368